|
CA13 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.032400E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.475600E-02 |
| Normal-vs-Stage2 |
2.986600E-01 |
| Normal-vs-Stage3 |
6.089700E-02 |
| Normal-vs-Stage4 |
5.893000E-01 |
| Stage1-vs-Stage2 |
5.173200E-01 |
| Stage1-vs-Stage3 |
9.996600E-01 |
| Stage1-vs-Stage4 |
4.013800E-01 |
| Stage2-vs-Stage3 |
5.878400E-01 |
| Stage2-vs-Stage4 |
7.826600E-01 |
| Stage3-vs-Stage4 |
4.326800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.536400E-03 |
| Normal-vs-AfricanAmerican |
1.281200E-01 |
| Normal-vs-Asian |
3.078200E-01 |
| Caucasian-vs-AfricanAmerican |
1.212170E-01 |
| Caucasian-vs-Asian |
8.154400E-01 |
| AfricanAmerican-vs-Asian |
7.640000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.076200E-03 |
| Normal-vs-Female |
2.112000E-01 |
| Male-vs-Female |
9.954000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.380090E-02 |
| Normal-vs-Extreme_Weight |
3.000200E-03 |
| Normal-vs-Obese |
2.243400E-01 |
| Normal-vs-Extreme_Obese |
9.276300E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.540200E-01 |
| Normal_Weight-vs-Obese |
2.121000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.522400E-01 |
| Extreme_Weight-vs-Obese |
1.654790E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.703400E-01 |
| Obese-vs-Extreme_Obese |
5.089400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.289000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.504100E-02 |
| Normal-vs-Age(61-80Yrs) |
3.657000E-03 |
| Normal-vs-Age(81-100Yrs) |
2.595100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.544000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.840190E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.742300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.907700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.578100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.586000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.255950E-02 |
| Normal-VS-Type2 PRCC |
1.197030E-04 |
| Normal-VS-KIRP CIMP |
3.821800E-01 |
| Normal-VS-Unclassified PRCC |
5.060200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.385990E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.290250E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.847200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.416500E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
2.570400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.923600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.400800E-03 |
| Normal-vs-N1 |
1.393640E-01 |
| Normal-vs-N2 |
1.962990E-01 |
| N0-vs-N1 |
2.915800E-01 |
| N0-vs-N2 |
9.762400E-01 |
| N1-vs-N2 |
6.465200E-01 |
|
|
